Conference Correspondent

People from lower socioeconomic backgrounds, minority groups, and rural areas are not well represented in clinical trials and biobanking, hampering research on health disparities.
Scalp cooling devices that allow patients treated with chemotherapy to retain their hair are used more commonly in Europe than in the United States, but this may be about to change now that the FDA has approved 2 scalp cooling devices: the DigniCap (approved in 2015) and the Paxman scalp cooling device (approved in 2017).
At the 2017 Annual Meeting of the Multinational Association of Supportive Care in Cancer, Dr. Jeanne Carter shared research from her program at MSKDD to update attendees on current finding, newer assessment instruments, and clinical tools to identify sexual health concern in women with cancer.

Results 1 - 3 of 3

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code